References
Stillman AE, Wilke N, Jerosch-Herold M. Use of an intravascular T1 contrast agent to improve MR cine myocardial-blood pool definition in man. J Magn Reson Imag 1997; 7(4): 765–767.
Wilke NM, Jerosch-Herold M, Zenovich A, et al. Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications. J Magn Reson Imag 1999; 10(5): 676–685.
Jerosch-Herold M, Wilke N, Stillman AE. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 1998; 25(1): 73–84.
Jerosch-Herold M, Wilke N, Wang Y, et al. Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Int J Cardiac Imag 1999; 15(6): 453–464.
Stillman AE, Wilke N, Jerosch-Herold M. Myocardial viability. Radiol Clin North Am 1999; 37(2): 361–378.
Marchal G, Ni Y, Herijgers P, et al. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol 1996; 6(1): 2–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stillman, A.E. New contrast agents for cardiovascular MRI and MRA. Int J Cardiovasc Imaging 17, 471–472 (2001). https://doi.org/10.1023/A:1020166005656
Issue Date:
DOI: https://doi.org/10.1023/A:1020166005656